Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: The comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol

Peter J. Blankestijn, Kathrin I. Fischer, Claudia Barth, Krister Cromm, Bernard Canaud, Andrew Davenport, Diederick E. Grobbee, Jörgen Hegbrant, Kit C. Roes, Matthias Rose, Giovanni F.M. Strippoli, Robin W.M. Vernooij, Mark Woodward, G. Ardine De Wit, Michiel L. Bots

Njurmedicin

University Medical Center Utrecht
Charité Universitätsmedizin Berlin
Fresenius Medical Care Deutschland GmbH
University of Montpellier
University College London
Julius Clinical
University of Massachusetts Medical School
University of Bari Aldo Moro
University of Sydney
University of Oxford
University of New South Wales
Johns Hopkins University
National Institute for Public Health and the Environment (RIVM)

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Sortera efter
Vikt
Alfabetisk ordning

Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: The comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol

Fingeravtryck

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science